SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-20-015912
Filing Date
2020-04-08
Accepted
2020-04-08 16:25:54
Documents
12
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A srpt-pre14a_20200604.htm PRE 14A 2533719
2 GRAPHIC gjsyxucwrv5n000007.jpg GRAPHIC 11419
3 GRAPHIC gjsyxucwrv5n000003.jpg GRAPHIC 3818
4 GRAPHIC gjsyxucwrv5n000004.jpg GRAPHIC 22639
5 GRAPHIC gjsyxucwrv5n000008.jpg GRAPHIC 82606
6 GRAPHIC gjsyxucwrv5n000001.jpg GRAPHIC 3818
7 GRAPHIC gjsyxucwrv5n000005.jpg GRAPHIC 9640
8 GRAPHIC gjsyxucwrv5n000011.jpg GRAPHIC 71394
9 GRAPHIC gjsyxucwrv5n000010.jpg GRAPHIC 74294
10 GRAPHIC gjsyxucwrv5n000006.jpg GRAPHIC 11306
11 GRAPHIC gjsyxucwrv5n000009.jpg GRAPHIC 12000
12 GRAPHIC gjsyxucwrv5n000002.jpg GRAPHIC 3818
  Complete submission text file 0001564590-20-015912.txt   2959126
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14895 | Film No.: 20782217
SIC: 2834 Pharmaceutical Preparations